Related Articles
Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases
Successful pazopanib treatment of undifferentiated pleomorphic sarcoma with coamplification of <em>PDGFRA</em>, <em>VEGFR2</em> and <em>KIT</em>: A case report
Elderberry interaction with pazopanib in a patient with soft‑tissue sarcoma: A case report and literature review
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age
lncRNA <em>HAR1B</em> has potential to be a predictive marker for pazopanib therapy in patients with sarcoma Corrigendum in /10.3892/ol.2021.12959